Markets › India › NSE › TATVA

Tatva Chintan Pharma Chem Ltd

NSE:TATVABasic Materials

₹1,903.40−2.09%At closeAt close · Mon 19 Oct · ≈ AED 73.54 · Market cap $477.52M · Next earnings Fri 30 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	42.8%	53.5%	45.1%	46.7%	16.2%	35.9%	—	—
Operating margin	41.9%	45.3%	33.5%	42.6%	2.4%	11.1%	11.1%	+0.0 pts
Net margin	19.0%	22.1%	10.7%	8.8%	1.5%	8.3%	8.3%	+0.0 pts
EBITDA margin	24.3%	25.0%	16.0%	20.1%	−22.9%	19.1%	—	—
Return on equity	31.5%	20.3%	8.8%	4.1%	0.8%	5.4%	5.4%	+0.0 pts
Return on assets	16.6%	14.6%	6.0%	3.7%	0.7%	4.2%	4.2%	+0.0 pts
Return on capital employed	58.7%	40.4%	27.2%	19.8%	1.2%	7.1%	—	—
Debt / equity	0.5×	0.3×	0.3×	0.0×	0.0×	0.2×	0.2×	+0.0%
Debt / assets	28.7%	18.2%	22.4%	1.7%	4.4%	12.0%	—	—
Interest coverage	26.6×	42.1×	17.0×	22.4×	7.0×	19.8×	—	—
Current ratio	1.6×	2.5×	1.3×	3.7×	2.8×	1.6×	1.6×	+0.0%
Quick ratio	1.0×	1.6×	0.6×	1.8×	1.4×	0.7×	—	—
Cash ratio	0.0×	0.4×	0.1×	0.4×	0.1×	0.0×	0.0×	+0.0%
Asset turnover	0.9×	0.7×	0.6×	0.4×	0.5×	0.5×	—	—
Inventory turnover	2.2×	1.2×	1.4×	1.2×	2.4×	1.7×	—	—
Receivables turnover	3.0×	7.1×	4.8×	4.7×	4.6×	4.2×	—	—
Dividend payout	7.7%	0.0%	9.7%	15.4%	81.9%	5.6%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.